Skip to main content
Skip to main content

AAP Gateway

Advanced Search »

User menu

  • Login
  • AAP Policy
  • Topic/Program Collections
  • Submit Manuscript
  • Alerts
  • Subscribe
  • Log out
  • aap.org

Menu

  • AAP Grand Rounds
  • AAP News
  • Hospital Pediatrics
  • NeoReviews
  • Pediatrics
  • Pediatrics in Review
  • Current AAP Policy
  • Journal CME
  • AAP Career Center
  • Pediatric Collections
  • AAP Journals Catalog

Sections

    • Login
    • AAP Policy
    • Topic/Program Collections
    • Submit Manuscript
    • Alerts
    • Subscribe
    • Log out
    • aap.org

    Sign up for Insight Alerts highlighting editor-chosen studies with the greatest impact on clinical care.
    Video Abstracts -- brief videos summarizing key findings of new articles
     

    Advertising Disclaimer »

    Tools and Links

    Pediatrics
    October 1954, VOLUME 14 / ISSUE 4
    Original Article

    LONGITUDINAL STUDY OF THE INCIDENCE OF CENTRAL NERVOUS SYSTEM DAMAGE FOLLOWING ERYTHROBLASTOSIS FETALIS

    MARGARET H. JONES, RUSSELL SANDS, CAROL B. HYMAN, PHILLIP STURGEON, FREMONT P. KOCH
    • Article
    • Info & Metrics
    • Comments
    Loading
    Download PDF

    Abstract

    One hundred unselected cases of erythroblastosis fetalis treated at Childrens Hospital in the newborn period have been followed from six months to five years in an effort to evaluate the relation of central nervous system signs in the newborn period to neuromuscular handicap and overall development later.

    Of those showing no central nervous system signs in the newborn period 4% showed definite abnormality later.

    Of those showing equivocal signs in the newborn period 33% showed definite abnormality later.

    Of those having definite signs early, 100% continued to show abnormality in infancy and childhood.

    There was no relation of the severity of the signs in the newborn period to the severity of the later handicap.

    It is suggested, therefore, that one cannot be certain of the later normality of an infant showing no definite or equivocal central nervous system involvement in the newborn period. Careful following of all erythroblastotic infants until six to eight years of age or longer is advisable.

    • Received May 10, 1954.
    • Copyright © 1954 by the American Academy of Pediatrics
    Full Text (PDF)
    PreviousNext

     

    Advertising Disclaimer »

    PreviousNext
    Email

    Thank you for your interest in spreading the word on Pediatrics.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    LONGITUDINAL STUDY OF THE INCIDENCE OF CENTRAL NERVOUS SYSTEM DAMAGE FOLLOWING ERYTHROBLASTOSIS FETALIS
    (Your Name) has sent you a message from Pediatrics
    (Your Name) thought you would like to see the Pediatrics web site.

    Alerts
    Sign In to Email Alerts with your Email Address
    Citation Tools
    LONGITUDINAL STUDY OF THE INCIDENCE OF CENTRAL NERVOUS SYSTEM DAMAGE FOLLOWING ERYTHROBLASTOSIS FETALIS
    MARGARET H. JONES, RUSSELL SANDS, CAROL B. HYMAN, PHILLIP STURGEON, FREMONT P. KOCH
    Pediatrics Oct 1954, 14 (4) 346-350;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    LONGITUDINAL STUDY OF THE INCIDENCE OF CENTRAL NERVOUS SYSTEM DAMAGE FOLLOWING ERYTHROBLASTOSIS FETALIS
    MARGARET H. JONES, RUSSELL SANDS, CAROL B. HYMAN, PHILLIP STURGEON, FREMONT P. KOCH
    Pediatrics Oct 1954, 14 (4) 346-350;
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    PDF
    Insight Alerts
    • Table of Contents
    • Current Policy
    • Early Release
    • Current Issue
    • Past Issues
    • Editorial Board
    • Editorial Policies
    • Overview
    • Features Video
    • Open Access
    • Pediatric Collections
    • Video Abstracts
    • Author Guidelines
    • Reviewer Guidelines
    • Submit My Manuscript

    Back to top

                

    Copyright © 2019 by American Academy of Pediatrics

    International Access »

    Terms of Use
    The American Academy of Pediatrics (AAP) takes the issue of privacy very seriously. See our Privacy Statement for information about how AAP collects, uses, safeguards and discloses the information collected on our Website from visitors and by means of technology.
    FAQ

     

    AAP Pediatrics